{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:36:03Z","timestamp":1785036963354,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Reseach Council of Norway","award":["262700"],"award-info":[{"award-number":["262700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10654-019-00595-2","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T08:03:27Z","timestamp":1577088207000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-1754","authenticated-orcid":false,"given":"Sara","family":"Ghaderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Berg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Johanne","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lill","family":"Trogstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Eldevik","family":"H\u00e5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"issue":"9648","key":"595_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7.","journal-title":"Lancet"},{"issue":"3","key":"595_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40263-015-0226-2","volume":"29","author":"EM Williamson","year":"2015","unstructured":"Williamson EM, Berger JR. Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs. 2015;29(3):229\u201344. https:\/\/doi.org\/10.1007\/s40263-015-0226-2.","journal-title":"CNS Drugs"},{"issue":"10","key":"595_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1212\/WNL.0000000000000753","volume":"83","author":"RA Marrie","year":"2014","unstructured":"Marrie RA, Elliott L, Marriott J, et al. Dramatically changing rates and reasons for hospitalization in multiple sclerosis. Neurology. 2014;83(10):929\u201337. https:\/\/doi.org\/10.1212\/WNL.0000000000000753.","journal-title":"Neurology"},{"issue":"8","key":"595_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/ene.12130","volume":"20","author":"S Montgomery","year":"2013","unstructured":"Montgomery S, Hillert J, Bahmanyar S. Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol. 2013;20(8):1153\u201360. https:\/\/doi.org\/10.1111\/ene.12130.","journal-title":"Eur J Neurol"},{"issue":"11","key":"595_CR5","first-page":"735","volume":"18","author":"C Evans","year":"2012","unstructured":"Evans C, Kingwell E, Zhu F, Oger J, Zhao Y, Tremlett H. Hospital admissions and MS: temporal trends and patient characteristics. Am J Manag Care. 2012;18(11):735\u201342.","journal-title":"Am J Manag Care"},{"issue":"1","key":"595_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0022-510X(98)00139-7","volume":"159","author":"J De Keyser","year":"1998","unstructured":"De Keyser J, Zwanikken C, Boon M. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci. 1998;159(1):51\u20133.","journal-title":"J Neurol Sci"},{"issue":"Pt 5","key":"595_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/brain\/awf098","volume":"125","author":"D Buljevac","year":"2002","unstructured":"Buljevac D, Flach HZ, Hop WC, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 2002;125(Pt 5):952\u201360.","journal-title":"Brain"},{"issue":"4","key":"595_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/01.wnl.0000233834.09743.3b","volume":"67","author":"J Correale","year":"2006","unstructured":"Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology. 2006;67(4):652\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000233834.09743.3b.","journal-title":"Neurology"},{"issue":"12","key":"595_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/WNL.59.12.1837","volume":"59","author":"OT Rutschmann","year":"2002","unstructured":"Rutschmann OT, McCrory DC, Matchar DB. Immunization panel of the multiple sclerosis council for clinical practice guidelines. Neurology. 2002;59(12):1837\u201343.","journal-title":"Neurology"},{"issue":"6","key":"595_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/1352458510394397","volume":"17","author":"M Oikonen","year":"2011","unstructured":"Oikonen M, Laaksonen M, Aalto V, et al. Temporal relationship between environmental influenza A and Epstein\u2013Barr viral infections and high multiple sclerosis relapse occurrence. Mult Scler. 2011;17(6):672\u201380. https:\/\/doi.org\/10.1177\/1352458510394397.","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"595_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2011.10.013","volume":"314","author":"E Auriel","year":"2012","unstructured":"Auriel E, Gadoth A, Regev K, Karni A. Seasonal and H1N1v influenza vaccines in MS: safety and compliance. J Neurol Sci. 2012;314(1\u20132):102\u20133. https:\/\/doi.org\/10.1016\/j.jns.2011.10.013.","journal-title":"J Neurol Sci"},{"key":"595_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8263-4","author":"MT Mailand","year":"2016","unstructured":"Mailand MT, Frederiksen JL. Vaccines and multiple sclerosis: a systematic review. J Neurol. 2016. https:\/\/doi.org\/10.1007\/s00415-016-8263-4.","journal-title":"J Neurol"},{"issue":"7","key":"595_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00415-011-5984-2","volume":"258","author":"MF Farez","year":"2011","unstructured":"Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol. 2011;258(7):1197\u2013206. https:\/\/doi.org\/10.1007\/s00415-011-5984-2.","journal-title":"J Neurol"},{"issue":"11","key":"595_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.4045\/tidsskr.11.1099","volume":"132","author":"IJ Bakken","year":"2012","unstructured":"Bakken IJ, Gystad SO, Christensen OO, et al. Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway. Tidsskr Nor Laegeforen. 2012;132(11):1336\u201340. https:\/\/doi.org\/10.4045\/tidsskr.11.1099.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"5","key":"595_CR15","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/ije\/dyx149","volume":"46","author":"S Ghaderi","year":"2017","unstructured":"Ghaderi S, Stordal K, Gunnes N, Bakken IJ, Magnus P, Haberg SE. Encephalitis after influenza and vaccination: a nationwide population-based registry study from Norway. Int J Epidemiol. 2017;46(5):1618\u201326. https:\/\/doi.org\/10.1093\/ije\/dyx149.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"595_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa1207210","volume":"368","author":"SE Haberg","year":"2013","unstructured":"Haberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368(4):333\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1207210.","journal-title":"N Engl J Med"},{"key":"595_CR17","unstructured":"Health TNIoP. Norwegian Surveillance System for Communicable Diseases (MSIS). The Norwegian Instiute of Public Health, Oslo, Norway. https:\/\/www.fhi.no\/en\/health-in-norway\/health-registries\/norwegian-surveillance-system-for-communicable-diseases-msis\/. Accessed 15 July 2016."},{"issue":"16","key":"595_CR18","doi-asserted-by":"crossref","first-page":"20147","DOI":"10.2807\/ese.17.16.20147-en","volume":"17","author":"L Trogstad","year":"2012","unstructured":"Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B. The Norwegian immunisation register\u2014SYSVAK. Euro Surveill. 2012;17(16):20147.","journal-title":"Euro Surveill"},{"issue":"2","key":"595_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86\u201394. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00494.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"15","key":"595_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.vaccine.2017.02.053","volume":"35","author":"L Trogstad","year":"2017","unstructured":"Trogstad L, Bakken IJ, Gunnes N, et al. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic. Vaccine. 2017;35(15):1879\u201385. https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.053.","journal-title":"Vaccine"},{"issue":"1","key":"595_CR21","doi-asserted-by":"publisher","first-page":"e30018","DOI":"10.1371\/journal.pone.0030018","volume":"7","author":"BF Blasio","year":"2012","unstructured":"Blasio BF, Iversen BG, Tomba GS. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway\u2014and the influence of vaccination timing. PLoS ONE. 2012;7(1):e30018. https:\/\/doi.org\/10.1371\/journal.pone.0030018.","journal-title":"PLoS ONE"},{"issue":"10","key":"595_CR22","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/sim.2302","volume":"25","author":"HJ Whitaker","year":"2006","unstructured":"Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768\u201397. https:\/\/doi.org\/10.1002\/sim.2302.","journal-title":"Stat Med"},{"key":"595_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13034","author":"C Metze","year":"2018","unstructured":"Metze C, Winkelmann A, Loebermann M, et al. Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies. CNS Neurosci Ther. 2018. https:\/\/doi.org\/10.1111\/cns.13034.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"595_CR24","first-page":"109","volume":"15","author":"SM Baghbanian","year":"2016","unstructured":"Baghbanian SM. Influenza vaccination in patients with multiple sclerosis is possible with some considerations. Iran J Neurol. 2016;15(2):109\u201310.","journal-title":"Iran J Neurol"},{"key":"595_CR25","doi-asserted-by":"publisher","first-page":"i4515","DOI":"10.1136\/bmj.i4515","volume":"354","author":"I Petersen","year":"2016","unstructured":"Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515. https:\/\/doi.org\/10.1136\/bmj.i4515.","journal-title":"BMJ"},{"issue":"24","key":"595_CR26","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1212\/WNL.0b013e318259e1b2","volume":"78","author":"AJ Solomon","year":"2012","unstructured":"Solomon AJ, Klein EP, Bourdette D. \u201cUndiagnosing\u201d multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012;78(24):1986\u201391. https:\/\/doi.org\/10.1212\/WNL.0b013e318259e1b2.","journal-title":"Neurology"},{"issue":"11","key":"595_CR27","doi-asserted-by":"publisher","first-page":"e01422","DOI":"10.1002\/brb3.1422","volume":"9","author":"E Benjaminsen","year":"2019","unstructured":"Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB. Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. Brain Behav. 2019;9(11):e01422. https:\/\/doi.org\/10.1002\/brb3.1422.","journal-title":"Brain Behav"},{"issue":"3","key":"595_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, Hauser SL, Kappos L, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med. 2017;376(3):209\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1606468.","journal-title":"N Engl J Med"},{"key":"595_CR29","unstructured":"Norwegian Institute of Public Health O. Influenza\u2014Fact sheet about seasonal influenza 2016. https:\/\/www.fhi.no\/en\/id\/influensa\/seasonal-influenza\/influenza\u2014fact-sheet-about-season\/. Accessed 1 July 2019."},{"issue":"3","key":"595_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/irv.12627","volume":"13","author":"SH Hauge","year":"2019","unstructured":"Hauge SH, Bakken IJ, de Blasio BF, Haberg SE. Burden of medically attended influenza in Norway 2008\u20132017. Influenza Other Respir Viruses. 2019;13(3):240\u20137. https:\/\/doi.org\/10.1111\/irv.12627.","journal-title":"Influenza Other Respir Viruses"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-019-00595-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-019-00595-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-019-00595-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T06:25:04Z","timestamp":1665296704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-019-00595-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1007\/s10654-019-00595-2","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics, South-East Region, Norway, and the Norwegian Data Protection Authority.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}